Het gebruik is uitsluitend voor onderzoeks- en laboratoriumdoeleinden niet goedgekeurd als geneesmiddel of supplement voor menselijk gebruik
METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
Our clinical professionals are experienced in serving the patients with personalized treatment that suits both health and weight loss
widely prescribed and very effective
G., & Alokail, M
And somewhere on the label, in small print, are four words that tell you everything: For Research Use Only